There is one ironclad rule when it comes to NBA analysis: it is never too soon to overreact. There is no sample size too small and no take too hot. I listened to a podcast last week weighing the MVP candidacy of New York Knickerbocker legend Julius Randle—a sentence that somehow sounds even less crazy today! And in the NBA, what’s happening off the court (and in the arena tunnels) is equally deserving of our attention. We crunched the numbers and looked at the advanced statistics to examine the early season returns on NBA style.
Here’s a brief hypothetical that illustrates the raw power of the best leather jackets for men: Let’s say you’re going to a party. (Remember those? We’re post-COVID in this hypothetical.) You aren’t even dressed yet, and your anxiety is already begging you to stay put, hoodie up, and introduce your old pal Thai food to your new boo Disney+. What are your options? You could gorge on a bunch of CBD on your way out the door—only, let’s be honest, that stuff is all a bit suspect. You could guzzle some good ol’ fashioned liquid courage the moment you arrive, …
LONDON — A British judge ruled on Monday that the WikiLeaks founder Julian Assange cannot be extradited to the United States to face trial on charges of violating the Espionage Act, saying he would be at extreme risk of suicide.
The decision in the high-profile case grants Mr. Assange a major victory against the U.S. authorities who charged him over his role in obtaining and publishing secret military and diplomatic documents related to the wars in Iraq and Afghanistan.
Rights groups and advocates applauded the ruling, but many expressed concern about its rationale. The judge focused on Mr. Assange’s mental
Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use on Monday, the country’s top epidemiologist, Hugo López-Gatell, announced in a tweet on Monday evening. It is the fourth country to approve the vaccine.
Mexico’s foreign secretary, Marcelo Ebrard, had previously said the approval was “imminent.”
Mr. Ebrard celebrated the approval on Monday evening as “very good news,” tweeting that it would allow the country to start production “very soon.” AstraZeneca said in August it would work with the Mexican and Argentine governments to produce 150 million initial doses for distribution across Latin America, and later produce at least 400 million